D-0527-2025 Class III Ongoing

Recalled by Orient Pharma Co., Ltd. Yunlin Plant — Yunlin County

FDA drug recall D-0527-2025 was initiated by Orient Pharma Co., Ltd. Yunlin Plant on Jun 11, 2025 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications. The recall status is ongoing. Affected quantity: 20618 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 9, 2025
Initiation Date
Jun 11, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20618 bottles

Product description

Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3631-98.

Reason for recall

Failed Impurities/Degradation Specifications.

Distribution pattern

NJ

Code information

P051001, P051002, & P051003, Exp Date 07/2025; P051005, Exp Date 10/2025; P051006, Exp Date 10/2025; P051007, Exp Date 01/2026; P051010, Exp Date 07/2026; P051011 & P051012, Exp Date 09/2026; P051013, P051014 and P051015, Exp Date 01/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0527-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0527-2025. Report a data issue: hello@regdatalab.com.